Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1130080.RAlYxlOBixOJffldq1zSQLagc5k_gc836ifERcaQuk8FY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1130080.RAlYxlOBixOJffldq1zSQLagc5k_gc836ifERcaQuk8FY130_assertion type Assertion NP1130080.RAlYxlOBixOJffldq1zSQLagc5k_gc836ifERcaQuk8FY130_head.
- NP1130080.RAlYxlOBixOJffldq1zSQLagc5k_gc836ifERcaQuk8FY130_assertion description "[Through gain- and loss-of-function studies, miR-26a was demonstrated to significantly inhibit vascular endothelial growth factor A (VEGFA) expression in HCC cells and then suppress the promoting effects of HCC cells on in vitro proliferation, migration, and capillary tube formation of endothelial cells, as well as in vivo tumor angiogenesis of HCC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1130080.RAlYxlOBixOJffldq1zSQLagc5k_gc836ifERcaQuk8FY130_provenance.
- NP1130080.RAlYxlOBixOJffldq1zSQLagc5k_gc836ifERcaQuk8FY130_assertion evidence source_evidence_literature NP1130080.RAlYxlOBixOJffldq1zSQLagc5k_gc836ifERcaQuk8FY130_provenance.
- NP1130080.RAlYxlOBixOJffldq1zSQLagc5k_gc836ifERcaQuk8FY130_assertion SIO_000772 24259426 NP1130080.RAlYxlOBixOJffldq1zSQLagc5k_gc836ifERcaQuk8FY130_provenance.
- NP1130080.RAlYxlOBixOJffldq1zSQLagc5k_gc836ifERcaQuk8FY130_assertion wasDerivedFrom befree-2016 NP1130080.RAlYxlOBixOJffldq1zSQLagc5k_gc836ifERcaQuk8FY130_provenance.
- NP1130080.RAlYxlOBixOJffldq1zSQLagc5k_gc836ifERcaQuk8FY130_assertion wasGeneratedBy ECO_0000203 NP1130080.RAlYxlOBixOJffldq1zSQLagc5k_gc836ifERcaQuk8FY130_provenance.